Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 3 February

Sophia Mavridis
February 3, 2023

Closing Bell 2 February

Grady Wulff
February 3, 2023

Morning Bell 2 February

Grady Wulff
February 2, 2023

Closing Bell 1 February

Grady Wulff
February 1, 2023

Morning Bell 1 February

Grady Wulff
February 1, 2023

Closing Bell 31 January

Grady Wulff
February 1, 2023

Morning Bell 31 January

Sophia Mavridis
January 31, 2023

Closing Bell 30 January

Grady Wulff
January 30, 2023

Morning Bell 30 January

Grady Wulff
January 30, 2023

Closing Bell 25 January

Grady Wulff
January 25, 2023

Morning Bell 25 January

Grady Wulff
January 25, 2023

Closing Bell 24 January

Grady Wulff
January 24, 2023